Pulmonology
<ѻýҕl class='mpt-top_cat_title_description'>News, opinions and meeting coverage in pulmonology.ѻýҕl>
<ѻýҕl>ESC: Mixed Results with Steroids in TB Pericarditisѻýҕl>
BARCELONA -- Adding steroids to anti-tuberculosis treatment for patients with tuberculous pericarditis can reduce the risk of complication and the resulting hospital admission, but adding prednisolone to tuberculosis treatment did not reduce the risk of death, researchers said here.
Sep 03, 2014
<ѻýҕl>Lung Foam Disappoints in COPDѻýҕl>
SAN DIEGO -- A trial of hydrogel-based lung volume reduction therapy in patients with chronic obstructive pulmonary disease (COPD) complicated by emphysema failed to show consistent enough results and has been abandoned by the agent's developer, researchers said here.
May 20, 2014
<ѻýҕl>FDA Slashes Starting Dose for Lunestaѻýҕl>
SILVER SPRING, Md. -- Patients starting on the sleep drug eszopiclone (Lunesta) should take no more than 1 mg at bedtime -- one-third the current label-recommended dose -- because of the risk of next-day impairment, the FDA said Thursday.
May 15, 2014
<ѻýҕl>Murder: Another Ambien Side Effect?ѻýҕl>
NEW YORK CITY -- Forensic psychiatrists are facing new challenges with murders committed by people under the influence of the sleep drug zolpidem (Ambien) -- not least to persuade the criminal justice system to take their conclusions seriously.
May 07, 2014
<ѻýҕl>APA Meeting Highlights Mental Health Biologyѻýҕl>
NEW YORK CITY -- The biological basis for normal and abnormal mental function is emerging as a dominant theme in psychiatry research, and the American Psychiatric Association annual meeting that starts here Saturday won't be an exception.
May 01, 2014